Both contain the same active ingredient and work through the same hormonal pathways
Strengths include a large sample size, a long follow-up period, a broad BMI range, standardized adiposity measurements, and rigorous event adjudication
Other observed adverse events in trials have included upper respiratory tract infections, urinary tract infections, and gallbladder-related effects (which are a known class effect of GLP-1 receptor agonists)
Beyond Weight Weight loss with retatrutide might assist in reducing the risk of heart disease
This doubling of the initial dose provides increased metabolic signaling without creating abrupt physiological changes
However, it also plays a potential role in cancer where it supplies tumors with the oxygen and nutrients needed to grow and spread